Background Remdesivir is an antiviral medicine approved for the treatment of mild‐to‐
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …

Post-COVID cognitive dysfunction (PCCD) is a condition in which patients with a history of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, usually three …

Objectives: Identify the treatment indications for chloroquine and hydroxychloroquine.
Determine the mechanisms of action of chloroquine and hydroxychloroquine. Identify the …

In this study, we propose our novel benzophenone–coumarin derivatives (BCDs) as potent
inhibitors of the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 virus, one of the …

Background. Molnupiravir (MOL) and nirmatrelvir/ritonavir (NIR) were recently approved for
the early treatment of COVID-19, but real-life data on tolerability, safety, and adverse events …

Background Remdesivir is an antiviral medicine approved for the treatment of mild‐to‐
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …

Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …

The worldwide pandemic of coronavirus disease 2019 (COVID-19) was known to
predominantly affect the lungs, but it was realized that COVID-19 had a large variety of …

Drug repurposing is a major field of value-added medicine. It involves investigating and
evaluating existing drugs for new therapeutic purposes that address unmet healthcare …

Since the spread of the deadly virus SARS-CoV-2 in late 2019, researchers have restlessly
sought to unravel how the virus enters the host cells. Some proteins on each side of the …